Professor Eugene McCloskey
MD, FRCPI
Clinical Medicine, School of Medicine and Population Health
Professor in Adult Bone Disease
Honorary Consultant
+44 114 215 9695
Full contact details
Clinical Medicine, School of Medicine and Population Health
Metabolic Bone Centre, Sorby Wing
Northern General Hospital
Herries Road
91直播
S5 7AU
- Profile
-
For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk
Born in Loughgiel, Northern Ireland, I studied medicine at Trinity College Dublin before arriving in 91直播 in 1985 via house officer posts in Ayrshire.
- Research interests
-
I developed my longstanding interest in metabolic bone diseases via an MRC Training Fellowship. My initial interests were in the field of malignant bone disease, but subsequently focussed on osteoporosis. I have been the principal investigator in a number of MRC and pharmaceutical industry-funded studies.
I am an acknowledged expert in the fields of vertebral fracture definition, osteoporosis epidemiology as well as non-invasive assessments of bone strength and fracture risk. I have published over 150 peer-reviewed articles, book chapters, guidelines, and reviews.
Current Projects
- FRAX and fracture risk assessment
- Interaction between physical and pharmaceutical interventions
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . The Lancet, 391(10122), 741-747.
- . Osteoporos Int, 23(9), 2239-2256.
- . Osteoporos Int, 22(9), 2395-2411.
- . Osteoporos Int, 20(5), 811-817.
- . Osteoporos Int, 19(10), 1395-1408.
- . Osteoporosis International, 19(4), 385-397.
- . Bone, 42(3), 467-475.
- . J Bone Miner Res, 22(1), 135-141.
- . Bone, 35(2), 375-382.
- . Journal of Clinical Oncology, 20(15), 3219-3224.
- . Br J Haematol, 113(4), 1035-1043.
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 100(2), 317-325.
- . Osteoporos Int, 3(3), 138-147.
All publications
Journal articles
- . Gaceta M茅dica de M茅xico, 160(4).
- . Osteoporosis International, 1-10.
- . Journal of Bone and Mineral Research, 39(6), 661-671.
- . Osteoporosis and Sarcopenia.
- . European Urology Oncology.
- . Journal of Clinical Densitometry, 27(1), 101452-101452.
- . Archives of Osteoporosis, 19(1), S269-S269.
- . Archives of Osteoporosis, 18(1).
- . Journal of Clinical Densitometry, 101429-101429.
- . Journal of Clinical Densitometry, 26(4), 101430-101430.
- . Revista Colombiana de Reumatolog铆a (English Edition), 30(3), 199-206.
- . Journal of Clinical Densitometry, 101415-101415.
- . Archives of Osteoporosis, 18.
- . Journal of Bone and Mineral Research.
- . Journal of Clinical Densitometry.
- . Journal of Bone and Mineral Research.
- . Journal of Cachexia, Sarcopenia and Muscle.
- Award of top experts and collaborators of the Society for Metabolic Diseases of the Skeleton 膶LS JEP. Clinical Osteology(3), 49.
- . Journal of Clinical Densitometry, 101378-101378.
- . Clinical Kidney Journal, 16(3), 456-472.
- . Bone, 116651-116651.
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . JBMR Plus.
- . Aging Clinical and Experimental Research, 34(12), 3155-3157.
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . Calcif Tissue Int.
- . Archives of Osteoporosis, 17(1).
- . J Bone Miner Res.
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . Therapeutic Advances in Musculoskeletal Disease, 14.
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . Archives of Osteoporosis, 17(1).
- . Osteoporosis International.
- . Osteoporosis International.
- . Archives of Osteoporosis, 16(1).
- . Osteoporos Int.
- . Aging Cell.
- . Osteoporosis International.
- . Climacteric, 1-7.
- . Journal of Osteoporosis, 2021, 1-7.
- . Archives of Osteoporosis, 16(1).
- . Archives of Osteoporosis, 16(1).
- . Arch Osteoporos, 16(1), 82.
- . Osteoporosis International.
- . Archives of Osteoporosis, 16.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International.
- . The Journal of Clinical Endocrinology & Metabolism, 106(4), e1931-e1931.
- . Osteoporosis International, 32(10), 1973-1979.
- . Archives of Osteoporosis, 16(1).
- . Archives of Osteoporosis, 16.
- . Archives of Osteoporosis, 16.
- . Genome Medicine, 13(1).
- . Osteoporosis International.
- . PLoS ONE, 16(2).
- . Journal of Bone and Mineral Research.
- . Arthritis Research & Therapy, 23(1).
- . Osteoporosis International, 32(1), 75-84.
- . Osteoporosis International, 32(1), 113-122.
- . Osteoporosis International, 32(1), 93-99.
- . Revista Colombiana de Reumatologia.
- . Osteoporosis International, 32(5), 817-829.
- . Osteoporosis International, 32(1), 165-171.
- . The Journal of Clinical Endocrinology & Metabolism, 106(1), 264-281.
- . Osteoporosis International, 32(1), 47-54.
- . Bone, 143, 115715-115715.
- . Bone, 144.
- . PLoS ONE, 15(12).
- . Bone Reports, 13.
- . Journal of Bone Oncology, 25.
- . Archives of Osteoporosis, 15(1).
- . Archives of Osteoporosis, 15(1).
- . Archives of Osteoporosis, 15(1).
- . Archives of Osteoporosis, 15(1).
- . Archives of Osteoporosis, 15(1).
- . Archives of Osteoporosis, 15(1).
- . JAMA, 324(18), 1855-1855.
- . Bone & Joint Research, 9(11), 808-820.
- . Journal of Medical Internet Research, 22(10).
- . Osteoporosis International.
- . Current Medical Research and Opinion.
- . Bone Reports, 13, 100677-100677.
- . International Journal of Medical Informatics, 142.
- . Osteoporosis International, 31(11), 2063-2067.
- . Osteoporosis International.
- . Archives of Osteoporosis, 15(1).
- . PLoS Medicine, 17(7).
- . Osteoporosis International, 31(10), 1817-1828.
- . The Journal of Clinical Endocrinology & Metabolism.
- . Journal of the Endocrine Society, 4(Supplement_1).
- . Archives of Osteoporosis, 15(1).
- . Osteoarthritis and Cartilage, 28(9), 1180-1190.
- . Nature Reviews Endocrinology, 16(8), 437-447.
- . Osteoporosis International, 31(6), 1059-1067.
- . Osteoporosis International, 31(3), 457-464.
- . Osteoporosis International, 31(4), 797-798.
- . Aging Clinical and Experimental Research, 32(2), 187-196.
- . Osteoporosis International, 31(6), 1079-1087.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International, 31(12), 2271-2286.
- . Osteoporosis International, 31(6), 1179-1180.
- . Diabetes Care, 43(1), 137-144.
- . JAMA Network Open, 3(1).
- . Osteoporosis International, 31(1), 1-12.
- . Journal of Public Health, 42(4), e440-e448.
- . Bone, 131.
- . Archives of Osteoporosis, 14(1).
- . Archives of Osteoporosis, 14(1).
- . Archives of Osteoporosis, 14(1).
- . Journal of Magnetic Resonance Imaging.
- . Value in Health, 22, S705-S706.
- . Bone, 127, 401-418.
- . IEEE Transactions on Medical Imaging.
- . Advances in Therapy, 36(10), 2811-2824.
- . Calcified Tissue International, 105(2), 125-126.
- . Osteoporosis International, 30(11), 2195-2203.
- . Calcified Tissue International, 105(1), 1-14.
- . The Oncologist, 24(11), 1432-1438.
- . Osteoporosis International, 30(9), 1733-1743.
- . Journal of Bone and Mineral Research, 34(8), 1428-1435.
- . Osteoarthritis and Cartilage, 27, S229-S229.
- . Osteoporosis International, 30(3), 537-539.
- . Osteoporosis International.
- . Calcified Tissue International, 105(2), 109-124.
- . Osteoporosis International, 30(2), 525-526.
- . Osteoporosis International, 30(11), 2225-2230.
- . Osteoporosis International, 30(9), 1745-1754.
- . Journal of Bone and Mineral Research, 33(12), 2150-2157.
- . Journal of Cachexia, Sarcopenia and Muscle, 9(7), 1272-1274.
- . Biomechanics and Modeling in Mechanobiology, 17(6), 1715-1730.
- . Archives of Osteoporosis, 13(1).
- . Archives of Osteoporosis, 13(1).
- . Archives of Osteoporosis, 13(1).
- . Journal of Clinical Densitometry, 21(4), 603-603.
- . American Journal of Epidemiology, 187(10), 2252-2262.
- . Age and Ageing, 47(6), 774-777.
- . Age and Ageing, 47, iv1-iv19.
- . Journal of Cachexia, Sarcopenia and Muscle, 9(4), 788-790.
- . The Lancet, 392(10147), 552-553.
- . Bone, 113, 161-168.
- . Journal of Bone and Mineral Research, 33(11), 1923-1930.
- . Journal of Bone and Mineral Research, 33(6), 1020-1026.
- . Osteoporosis International, 29(8), 1747-1757.
- . Osteoporosis International, 29(7), 1511-1513.
- . Journal of Osteoporosis, 2018.
- . Osteoporosis International, 29(6), 1367-1378.
- . Osteoporosis International, 29(6), 1407-1417.
- . Journal of Bone and Mineral Research, 33(5), 845-851.
- . Journal of Cachexia, Sarcopenia and Muscle, 9(2), 269-278.
- . Journal of Clinical Endocrinology and Metabolism, 103(4), 1302-1309.
- . Bone, 110, 386-391.
- . Journal of Bone and Mineral Research, 33(3), 510-516.
- . The Lancet, 391(10122), 741-747.
- . Osteoporosis International, 29(3), 759-767.
- . Osteoporosis International, 29(3), 751-758.
- . Osteoporosis International, 29(3), 741-749.
- . Bone, 106, 69-77.
- . Quality of Life Research, 27(3), 707-716.
- . Osteoporosis International, 29(3), 557-566.
- . Clinical Nutrition, 37(4), 1121-1132.
- . International Journal of Osteoporosis and Metabolic Disorders, 11(1), 7-13.
- . Archives of Osteoporosis, 12(1).
- . Archives of Osteoporosis, 12(1), 43-43.
- . The Lancet, 390(10109), 2243-2244.
- . The Journal of Clinical Endocrinology & Metabolism, 102(11), 4242-4249.
- . Osteoporosis International, 28(11), 3099-3105.
- . Osteoporosis International, 28(11), 3285-3286.
- . Journal of Clinical Densitometry, 20(3), 360-367.
- . Innovation in Aging, 1(suppl_1), 693-693.
- . Journal of Clinical Densitometry, 20(3), 444-450.
- . Osteoporosis International.
- . JAMA Psychiatry, 74(6), 641-648.
- . Bone, 99, 39-46.
- . Archives of Osteoporosis, 12.
- . Journal of Bone and Mineral Research, 32(8), 1625-1631.
- . Revue du Rhumatisme, 84(3), 196-198.
- . Osteoporosis International, 28(5), 1507-1529.
- . Osteoporosis International, 28(7), 2023-2034.
- . Osteoporos Int.
- . American Journal of Gastroenterology, 112(6), 974-974.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International, 28(3), 775-780.
- . Osteoporosis International, 28(6), 1817-1833.
- . Journal of the Formosan Medical Association, 116(3), 161-168.
- . Osteoporosis International, 28(1), 71-76.
- . Archives of Osteoporosis, 11(1).
- . The Journal of Clinical Endocrinology & Metabolism, 101(11), 4489-4496.
- . BMC Geriatrics, 16(1).
- . Joint Bone Spine, 83(5), 477-478.
- . Osteoporosis International, 27(9), 2689-2695.
- . Bone, 92, 94-99.
- . Journal of Clinical Densitometry, 19(3), 326-331.
- . European Geriatric Medicine, 7(3), 243-246.
- . Journal of Bone and Mineral Research, 31(5), 940-948.
- . Current Opinion in Rheumatology, 28(4), 433-441.
- . npj Genomic Medicine, 1(1).
- . Journal of Bone and Mineral Research, 31(3), 640-649.
- . Aging Clinical and Experimental Research, 28(1), 47-58.
- . Aging Clinical and Experimental Research, 28(1), 1-16.
- . Osteoporosis International, 27(1), 267-274.
- . Osteoporosis International, 27(1), 417-419.
- . Genes & Immunity, 17(1), 46-51.
- . Osteoporosis International, 27(1), 21-31.
- . Osteoporosis International, 27(1), 37-37.
- . PLoS ONE, 10(12).
- . Calcified Tissue International, 98(5), 417-425.
- . Archives of Osteoporosis, 10(1).
- . Osteoporosis International, 26(11), 2617-2622.
- . Climacteric, 18(sup2), 2-9.
- . Osteoporosis International, 26(9), 2347-2353.
- . Osteoporosis International, 26(9), 2243-2248.
- . Osteoporosis International, 26(11), 2677-2684.
- . Osteoporosis International, 26(8), 2091-2099.
- . Bone, 78, 216-224.
- . The Journal of Clinical Endocrinology & Metabolism, 100(5), 2063-2070.
- . Journal of Bone and Mineral Research, 30(4), 615-620.
- . Calcified Tissue International, 96(6), 500-509.
- . Osteoporosis International, 26(7), 1979-1987.
- . International Journal of Clinical Rheumatology, 10(1), 1-4.
- . The Journal of Clinical Endocrinology & Metabolism, 100(8), 3219-3219.
- . Journal of Bone and Mineral Research, 30(10), 1747-1753.
- . Osteoporosis International, 26(1), 123-130.
- . The Journal of Clinical Endocrinology & Metabolism, 100(8), 3219-3219.
- . Arch Osteoporos, 9, 166.
- . Journal of Bone and Mineral Research, 29(11), 2511-2519.
- . Calcified Tissue International, 95(5), 428-435.
- . Osteoporosis International, 25(12), 2729-2741.
- . J Bone Miner Res, 29(9), 1926-1928.
- . Osteoporosis International.
- . BoneKEy Reports, 3.
- . Value in Health, 17(3), A48-A49.
- . JOURNAL OF BONE AND MINERAL RESEARCH, 29(5), 1074-1080.
- . J Bone Miner Res, 29(10), 2217-2223.
- . Human Molecular Genetics, 23(7), 1923-1933.
- . Calcif Tissue Int, 94(5), 560-567.
- . Journal of Bone and Mineral Research, 29(3), 518-530.
- Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus.. Bone, 59, 20-27.
- . Bone, 59, 20-27.
- . Journal of Bone and Mineral Research, 29(1), 223-233.
- . Calcified Tissue International, 95(1), 39-45.
- . Osteoporosis International, 25(7), 1831-1836.
- . Osteoporosis International, 25(10), 2445-2451.
- . Calcified Tissue International, 95(5), 419-427.
- . Osteoporosis International, 25(1), 61-69.
- . Osteoporosis International, 25(11), 2533-2543.
- . Osteoporos Int, 25(1), 235-241.
- . Osteoporos Int, 25(1), 251-263.
- . Human Molecular Genetics, 23(11), 3054-3068.
- . Archives of Osteoporosis, 8(1-2).
- . Archives of Osteoporosis, 8(1-2).
- SCOPE: a scorecard for osteoporosis in Europe.. Archives of osteoporosis, 8(1-2), 144.
- . Archives of Osteoporosis, 8(1-2).
- . Calcified Tissue International, 92(5), 429-436.
- . Archives of Osteoporosis, 8(1-2).
- . Archives of Osteoporosis, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Slovakia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Greece. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in UK. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Lithuania. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Luxembourg. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Germany. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Denmark. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Cyprus. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in the Czech Republic. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Spain. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Italy. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Sweden. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in the Netherlands. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Slovenia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Bulgaria. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Portugal. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Austria A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Finland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Belgium. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Ireland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in France. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Poland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Latvia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Romania. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Hungary. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Malta. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Epidemiology and Economic Burden of Osteoporosis in Estonia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
- Assessing fracture risk in patients with osteoporosis. Practitioner, 257(1765), 19-21.
- . Value in Health, 16(7), A573-A574.
- . Journal of Clinical Densitometry, 16(4), 570-578.
- . Journal of Clinical Densitometry, 16(3), 267-268.
- . Journal of Bone and Mineral Research, 28(5), 1007-1013.
- . BMJ, 346(mar12 3), f1427-f1427.
- . Bone, 53(1), 188-193.
- . Bone, 53(1), 134-144.
- . Journal of Bone and Mineral Research, 28(3), 439-441.
- . Osteoporosis International, 24(3), 811-823.
- . The Journal of Clinical Endocrinology & Metabolism, 98(2), 818-828.
- . Maturitas.
- . Maturitas.
- . Journal of Clinical Densitometry.
- . Maturitas.
- . Rheumatology International, 1-9.
- . HIV Medicine, 14, 1-11.
- . Osteoporosis International, 24(1), 391-392.
- . J Bone Miner Res, 28(5), 1014-1021.
- . Calcif Tissue Int, 92(1), 42-49.
- . Osteoporos Int, 24(1), 23-57.
- . Archives of Osteoporosis, 7(1-2), 229-235.
- . Archives of Osteoporosis, 7(1-2), 67-73.
- . Osteoporosis International, 23(10), 2507-2515.
- . Current Opinion in Rheumatology, 24(5), 554-560.
- . J Bone Miner Metab, 30(6), 700-705.
- . Clinical Biochemistry, 45(12), 887-893.
- . Osteoporos Int, 23(9), 2401-2402.
- . Journal of Bone and Mineral Research, 27(6), 1243-1251.
- . Journal of Bone and Mineral Research, 27(6), 1390-1396.
- . Bone, 50, S14-S14.
- . J Bone Miner Res, 27(7), 1480-1486.
- . Osteoporos Int, 23(9), 2239-2256.
- . Osteoporosis International, 23(3), 853-860.
- . Osteoporosis International, 23(3), 907-915.
- . Osteoporosis International, 23(3), 991-999.
- . Osteoporosis International, 23(2), 643-654.
- . Osteoporosis International, 23(2), 423-431.
- . Journal of Bone and Mineral Research, 27(2), 301-308.
- . Archives of Osteoporosis, 7(1-2), 209-218.
- . Archives of Osteoporosis, 7(1-2), 237-246.
- . Archives of Osteoporosis, 7(1-2), 25-30.
- . Osteoporosis International, 23(9), 2257-2276.
- . Nature Genetics, 44(5), 491-501.
- A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis International, 1-18.
- . Journal of Clinical Densitometry, 15(1), 1-20.
- . Calcified Tissue International, 90(1), 1-13.
- . Osteoporosis International, 23(1), 391-397.
- . Osteoporosis International, 23(1), 75-85.
- . Journal of Infection, 63(6), e39-e40.
- . OSTEOPOROSIS INT, 22(9), 2507-2512.
- . Osteoporos Int, 22(9), 2395-2411.
- . J Clin Densitom, 14(3), 220-222.
- . J Clin Densitom, 14(3), 181-183.
- . Osteoporos Int, 22(8), 2357-2358.
- . Osteoporosis International, 22(5), 1411-1418.
- . PLoS Genetics, 7(4).
- . Journal of Clinical Densitometry, 14(2), 161-161.
- . Osteoporosis International, 22(3), 829-837.
- . Osteoporosis International, 22(3), 839-847.
- . Osteoporosis International, 22(3), 817-827.
- . Osteoporosis International, 22(3), 955-965.
- . Bone, 49(1), 71-76.
- . Osteoporos Int, 22(8), 2347-2355.
- . Nature Reviews Endocrinology, 7(7), 383-384.
- . Osteoporos Int, 22(3), 809-816.
- . Archives of Osteoporosis, 6(1-2), 179-188.
- . Archives of Osteoporosis, 6(1-2), 59-155.
- . Journal of Bone and Mineral Research, 26(10), 2411-2418.
- . Journal of Clinical Densitometry, 14(3), 212-219.
- . Journal of Clinical Densitometry, 14(3), 171-180.
- Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model. Archives of Osteoporosis, 1-10.
- . Future Virology, 6(6), 769-782.
- Adjustment of the FRAX (R) for the Glucocorticoid Dosis. OSTEOLOGIE, 20(1), 82-83.
- . Osteoporos Int, 22(8), 2359-2364.
- . Osteoporos Int, 22(2), 453-461.
- . Osteoporosis International, 22(3), 771-780.
- Calculating fracture risk in primary care. Practitioner, 254(1725), 7.
- . Archives of Osteoporosis, 5(1-2), 19-48.
- . Journal of Bone and Mineral Research, 25(11), 2350-2358.
- . Bone, 47(2), 430-437.
- HIV and bone disease. Archives of Biochemistry and Biophysics.
- . Bone, 47(4), 729-735.
- . Bone, 47, S227-S227.
- . Bone, 47, S211-S211.
- . Bone, 47, S163-S163.
- . Osteoporos Int, 21 Suppl 2, S407-S413.
- . Osteoporosis International, 21(5), 885-885.
- . RHEUMATOLOGY, 49(3), 505-512.
- . OSTEOPOROSIS INT, 21(3), 495-505.
- . European Journal of Cancer, 46(3), 558-565.
- . Osteoporosis International, 21(2), 339-349.
- , 605-611.
- . Archives of Biochemistry and Biophysics, 503(1), 66-77.
- An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women. Archives of Osteoporosis, 1-30.
- . Osteoporos Int, 21(1), 35-40.
- . Current Medical Research and Opinion, 25(12), 2951-2960.
- . Best Pract Res Clin Rheumatol, 23(6), 711-726.
- . Bone, 45(6), 1053-1058.
- . Osteoporos Int, 20(12), 2055-2061.
- . Med Decis Making, 29(6), 678-689.
- . Osteoporosis International, 20(10), 1675-1682.
- . Curr Osteoporos Rep, 7(3), 77-83.
- . Eur J Radiol, 71(3), 392-397.
- . Nat Rev Rheumatol, 5(8), 425-431.
- . Bone, 44(6), 1049-1054.
- . Value in Health, 12(3), A67-A67.
- . Bone, 44, S123-S124.
- . Osteoporos Int, 20(5), 811-817.
- . Bone, 44(5), 734-743.
- A history of thyroid disease and body composition in elderly women. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 39, 4-4.
- . Maturitas, 62(2), 105-108.
- A FRAX庐 model for the assessment of fracture probability in belgium. Revue Medicale de Liege, 64(12), 612-619.
- . Osteoporosis International, 20(3), 499-502.
- . J Bone Miner Res, 24(1), 33-42.
- . Clin Cancer Res, 14(20), 6387-6395.
- . Osteoporos Int, 19(10), 1395-1408.
- . J BONE MINER RES, 23(10), 1591-1600.
- . J Bone Miner Res, 23(10), 1561-1568.
- . Osteoporosis International, 19(8), 1105-1107.
- . J Clin Densitom, 11(3), 373-382.
- . Osteoporosis International, 19(4), 385-397.
- . OSTEOPOROSIS INT, 19(4), 593-594.
- . IBMS BoneKEy, 5(3), 114-117.
- . Bone, 42(3), 467-475.
- . J BONE MINER RES, 23(3), 409-416.
- . Journal of International Medical Research, 36(3), 400-413.
- . Menopause International, 14(1), 6-12.
- A method to estimate femoral neck cortical thickness from clinical QCT scans. CALCIFIED TISSUE INT, 82, S181-S182.
- . Cancer Treat Rev, 34 Suppl 1, S3-18.
- . Menopause International, 13(4), 197-197.
- . Eur J Cancer, 43(17), 2523-2531.
- . Calcif Tissue Int, 81(5), 341-351.
- . Clinical Cancer Research, 13(18), 5406-5410.
- . Osteoporosis International, 18(8), 1033-1046.
- . Osteoporosis International, 18(8), 1141-1143.
- . Journal of Clinical Oncology, 25(18_suppl), 560-560.
- . Bone, 40(5), 1209-1216.
- Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 11(7).
- . Annals of Oncology, 18(2), 393-393.
- . J Bone Miner Res, 22(1), 135-141.
- . Health Technol Assess, 11(7), iii-231.
- Effects of prior antiresorptive therapy on markers of bone formation after 6 months of teriparatide treatment in postmenopausal women with osteoporosis: Results from the eurofors trial. CALCIFIED TISSUE INT, 80, S137-S137.
- Effects of prior antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis: Final results from the EUROFORS trial. CALCIFIED TISSUE INT, 80, S30-S30.
- Clinical risk factors enhance the performance of BMD in the prediction of fractures. CALCIFIED TISSUE INT, 80, S29-S29.
- Use of DXA-based structural engineering models of the proximal femur to predict hip fracture. CALCIFIED TISSUE INT, 80, S25-S26.
- . OSTEOPOROSIS INT, 18(1), 35-43.
- . Journal of Clinical Oncology, 24(18_suppl), 555-555.
- . Future Rheumatology, 1(3), 289-291.
- . BoneKEy-Osteovision, 3(6), 5-13.
- . Breast Cancer Research, 8(3).
- . European Journal of Cancer, 42(8), 1044-1051.
- . OSTEOPOROSIS INT, 17(4), 535-542.
- , 415-426.
- , 399-414.
- . Breast Cancer Research, 8(2).
- . OSTEOPOROSIS INT, 16(11), 1330-1338.
- . Osteoporosis International, 16(7), 799-804.
- . Journal of Clinical Oncology, 23(16_suppl), 535-535.
- . Current Medical Research and Opinion, 21(5), 805-815.
- . Cancer Treatment Reviews, 31(2), 115-142.
- . Journal of Orthopaedic Surgery, 13(1), 27-33.
- . Dig Dis Sci, 50(3), 587-592.
- . Osteoporos Int, 16(2), 155-162.
- . BONE, 36(1), 47-51.
- . Bone, 35(5), 1029-1037.
- . Bone, 35(2), 375-382.
- . Journal of Clinical Oncology, 22(14_suppl), 528-528.
- . Journal of Clinical Oncology, 22(14_suppl), 8056-8056.
- . Journal of Clinical Oncology, 22(14_suppl), 528-528.
- . Journal of Clinical Oncology, 22(14_suppl), 8056-8056.
- . J BONE MINER RES, 19(7), 1172-1180.
- . Journal of Orthopaedic Surgery, 12(1), 133-133.
- . J BONE MINER RES, 19(6), 906-913.
- . J Bone Miner Res, 19(6), 893-899.
- EFFECT OF MEDICAL RISK FACTORS ON DXA MEASUREMENTS AND METACARPAL RADIOGRAPHIC INDICES. RHEUMATOLOGY, 43, 56-56.
- . Archives of Internal Medicine, 164(4), 420-420.
- Global variations in peak bone mass as studied by dual-energy X-ray absorptiometry. J RADIOANAL NUCL CH, 259(2), 341-345.
- Re: generations (Correction concerning a cast member in a recent production of 'Measure for Measure'). TLS-THE TIMES LITERARY SUPPLEMENT(5287), 15-15.
- . Calcified Tissue International, 74(1), 1-11.
- Oral clodronate as treatment of osteogenesis imperfecta. ARCH DIS CHILD, 88(10), 945-945.
- . Postgrad Med J, 79(936), 581-584.
- . European Journal of Cancer Supplements, 1(5), S127-S127.
- . Age and Ageing, 32(5), 553-553.
- Clodronate in the management of breast cancer and multiple myeloma.. Ortop Traumatol Rehabil, 5(2), 227-233.
- FRACTURE INCIDENCE IN ELDERLY WOMEN WITH SELF-REPORTED OSTEOARTHRTIS, RHEUMATOID ARTHRITIS OR CURRENT CORTICOSTEROID USE: ANALYSIS FROM THE MRC HIPS STUDY. RHEUMATOLOGY, 42, 112-112.
- . Eur J Gastroenterol Hepatol, 15(4), 407-413.
- . Drug Safety, 26(9), 661-671.
- . Food and Nutrition Bulletin, 23(3_suppl1), 180-184.
- . Journal of Clinical Oncology, 20(15), 3219-3224.
- Daily oral pamidronate in women and men with osteoporosis: A 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J BONE MINER RES, 17(6), 1057-1064.
- The incidence of vertebral fractures in men and women: The Rotterdam Study. J BONE MINER RES, 17(6), 1051-1056.
- SELF REPORTED RHEUMATOID ARTHRITIS AND CURRENT STEROID USE INCREASE THE RISK OF OSTEOPOROTIC FRACTURES IN ELDERLY WOMEN: A HIPS STUDY INTERIM REPORT. RHEUMATOLOGY, 41, 99-99.
- SELF REPORTED OSTEOARTHRITIS IS ASSOCIATED WITH A REDUCED RISK OF OSTEOPOROTIC FRACTURES IN ELDERLY WOMEN: A HIPS STUDY INTERIM REPORT. RHEUMATOLOGY, 41, 100-100.
- The relationship of adult coeliac disease with irritable bowel syndrome, iron deficiency anaemia and fatigue: A primary care cross-sectional study. GUT, 50, A18-A18.
- . Clinical Reviews in Bone and Mineral Metabolism, 1(2), 135-143.
- . Current Obstetrics and Gynaecology, 12(6), 354-357.
- Prevalence of osteoporosis and vertebral fractures and effect of oral bisphosphonates in successful orthotopic liver transplantation. A one-year open study. OSTEOPOROSIS INT, 13, S132-S132.
- Similar deleterious skeletal effects of intermittent or continuous oral corticosteroids in patients with COPD also using inhalation corticosteroids. OSTEOPOROSIS INT, 13, S131-S131.
- Low prevalence of osteoporosis and fractures and no significant bone loss at a year's follow-up in well controlled Crohn's disease. OSTEOPOROSIS INT, 13, S132-S132.
- Risk factors for incident vertebral fractures in men and women: The Rotterdam study. OSTEOPOROSIS INT, 13, S67-S67.
- Oral corticosteroids increase fracture risk independently of BMD. OSTEOPOROSIS INT, 13, S14-S14.
- Clinical risk factors for prediction of hip osteoporosis in elderly women. OSTEOPOROSIS INT, 13, S8-S8.
- . Sarcoma, 6(4), 131-133.
- Heel ultrasound discriminates osteoporotic males with or without vertebral fractures.. J BONE MINER RES, 16, S523-S523.
- Low prevalence of osteoporosis and fractures and no significant bone loss after one year follow-up in well controlled Crohn's disease.. J BONE MINER RES, 16, S522-S522.
- BMD independent risk factors for hip fractures in elderly women in England.. J BONE MINER RES, 16, S213-S213.
- . Br J Haematol, 113(4), 1035-1043.
- . Calcif Tissue Int, 68(6), 348-351.
- Sit-to-stand test, a simple predictor of hip and other fractures in older women. BONE, 28(5), S93-S93.
- . Joint Bone Spine, 68(3), 257-261.
- . Bone, 28(3), 310-315.
- . Revue du Rhumatisme, 68(5), 439-444.
- A randomised placebo controlled trial to evaluate the effect of the bisphosphonate, clodronate, on the incidence of metastases and mortality in patients with primary operable breast cancer. Breast Cancer Research and Treatment, 69(3), 209.
- Effect of clodronate on time to occurrence of skeletal complications in patients with breast cancer and bone metastases.. BREAST CANCER RES TR, 69(3), 305-305.
- . Drugs, 61(9), 1253-1274.
- . Maturitas, 37(2), 75-81.
- Young adult bone mineral density across diverse geographical and racial populations.. J BONE MINER RES, 15, S531-S531.
- Forearm BMD by digital X-ray radiogrammetry: Preliminary comparison of UK and US reference data.. J BONE MINER RES, 15, S531-S531.
- Risk indicators for incident vertebral fractures in men and women.. J BONE MINER RES, 15, S159-S159.
- Oral clodronate significantly reduces fracture risk in women with postmenopausal or secondary osteoporosis.. J BONE MINER RES, 15, S227-S227.
- . Cancer, 88(12 Suppl), 3022-3032.
- Vertebral osteophytosis and vertebral deformities in an elderly population sample. Wiener Klinische Wochenschrift, 112(9), 407-412.
- Clinical referral criteria for bone densitometry in younger women. OSTEOPOROSIS INT, 11, S1-S2.
- Social and geographical factors influencing local referrals for bone mineral densitometry. OSTEOPOROSIS INT, 11, S1-S1.
- . Bone, 26(5), 525-528.
- Age-related decrease in bone ultrasonometry in density-adjusted women. OSTEOPOROSIS INT, 11, S124-S124.
- Computing standardised bone mineral density with the Lunar Expert. OSTEOPOROSIS INT, 11, S70-S70.
- Comparative predictive ability of skeletal measurements for fragility fracture. OSTEOPOROSIS INT, 11, S100-S100.
- Osteoporosis. Hormone replacement therapy and breast cancer. Acta Ginecologica, 57(4), 99-100.
- . The Foot, 10(3), 169-171.
- Is a calculated total hip BMD of clinical use?. OSTEOPOROSIS INT, 11(4), 368-371.
- . Osteoporos Int, 11(11), 953-958.
- . Osteoporosis International, 10(2), 150-160.
- Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion. J BONE MINER RES, 14, 74-78.
- . European Journal of Cancer, 35, S83-S83.
- Oral clodronate prevents bone loss in elderly women over 3 years of treatment.. J BONE MINER RES, 14, S525-S525.
- Calcitonin gene receptor polymorphism is not associated with fracture risk factors in a random population sample.. J BONE MINER RES, 14, S231-S231.
- Questionnaire survey on current practice in renal osteodystrophy in the United Kingdom.. KIDNEY INT, 55(6), 2569-2569.
- Early renal and hepatic safety data for a shorter intravenous clodronate regimen in renal impairment.. KIDNEY INT, 55(6), 2595-2595.
- Intravenous clodronate 300 mg x 5 days has no deleterious effect on creatinine clearance in mild to moderate renal impairment.. KIDNEY INT, 55(5), 2107-2107.
- Preliminary comparison of tibial ultrasound velocity with bone mineral density in dialysis patients with marked hyperparathyroidism and with healthy volunteers.. KIDNEY INT, 55(5), 2101-2102.
- The distribution, determinants, and clinical correlates of vertebral osteophytosis: A population based survey. J RHEUMATOL, 26(4), 842-848.
- . QJM, 92(3), 143-149.
- . Br J Cancer, 79(7-8), 1179-1181.
- Economic impact of using clodronate in the management of patients with multiple myeloma. BRIT J HAEMATOL, 104(2), 358-364.
- . European Journal of Surgical Oncology (EJSO), 25(1), 3-23.
- . Osteoporos Int, 9 Suppl 2, S24-S28.
- The Guidelines for the management of metastatic bone disease in breast cancer in the United Kingdom. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 25(1), 4-23.
- How should osteoporosis during the postmenopause be approached?. GINEDIPS, 1(0), 25-27.
- . Maturitas, 30(3), 229-233.
- . Postgraduate Medical Journal, 74(877), 697-698.
- Short-term reproducibility of proximal femur bone mineral density in the elderly. CALCIFIED TISSUE INT, 63(4), 296-299.
- Oral clodronate reduces skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 102(1), 6-6.
- . Kennedy Institute of Ethics Journal, 8(2), vii-x.
- . JNCI: Journal of the National Cancer Institute, 90(9), 704-708.
- Economic impact of using clodronate in the management of patients with multiple myeloma. BRIT J HAEMATOL, 101, 46-46.
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 100(2), 317-325.
- . Hematology, 3(4), 291-298.
- . European Journal of Cancer, 33, S25-S25.
- Economic evaluation of the use of prophylactic Clodronate to treat multiple myeloma. EUR J CANCER, 33, PP29-PP29.
- . Cancer, 80(8 Suppl), 1691-1695.
- . Cancer, 80(8 Suppl), 1538-1545.
- . J Bone Miner Res, 12(10), 1700-1707.
- . European Journal of Cancer, 33, S80-S80.
- Ultrasound velocity and dexa in normal and pagetic bone.. J BONE MINER RES, 12, T682-T682.
- . Bone, 20(3), 263-271.
- . Journal of Bone and Mineral Metabolism, 15(4), 218-222.
- . Osteoporos Int, 7 Suppl 3, S179-S183.
- . Osteoporos Int, 7 Suppl 3, S140-S146.
- . Bone, 19(6), 663-667.
- . Bone, 19(1), 47-50.
- Assessment of osteopenia from spine radiographs using two different methods: The Chingford study. BRIT J RADIOL, 69(821), 451-456.
- . Maturitas, 23 Suppl, S81-S86.
- . Bone, 18(2), 185-190.
- . J Bone Miner Res, 11(2), 178-182.
- . Osteoporosis International, 6(S1), 134-134.
- . Osteoporosis International, 6(S1), 217-217.
- . Osteoporosis International, 6(S1), 271-271.
- . Osteoporosis International, 6(S1), 89-89.
- . Osteoporos Int, 6(1), 1-7.
- . Bone, 18(3 Suppl), 127S-132S.
- Sustained response to intravenous alendronate in postmenopausal osteoporosis. BONE, 17(6), 517-520.
- Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.. The Canadian journal of oncology, 5 Suppl 1, 54-57.
- . European Journal of Cancer, 31, S162-S162.
- . J Bone Miner Res, 10(7), 1094-1100.
- . Bone, 16(6), 683-683.
- . Bone, 16(6), 691-692.
- . Bone, 16(6), 692-692.
- . Bone, 16(6), 691-691.
- EVENTS PER PERSON YEAR - A DECREASE IN MULTIPLE EVENTS MAY BE MISSED. BRIT MED J, 310(6992), 1469-1469.
- . BMJ, 310(6992), 1469.
- . Journal of Clinical Oncology, 13(4), 929-934.
- ASSESSING VERTEBRAL FRACTURES. JOURNAL OF BONE AND MINERAL RESEARCH, 10(4), 518-523.
- Role of bisphosphonates in the medical management of hyperparathyroidism. Acta Chirurgica Austriaca, 26(SUPPL. 112), 6-7.
- CONSEQUENCES OF NEOPLASIA INDUCED BONE-RESORPTION AND THE USE OF CLODRONATE (REVIEW). INT J ONCOL, 5(4), 713-731.
- . Bone Miner, 27(1), 51-56.
- . Br J Cancer, 69(5), 914-917.
- . Ann Clin Biochem, 31 ( Pt 3), 272-276.
- . Osteoporosis International, 4(2), 117-119.
- ASSESSING VERTEBRAL DEFORMITIES. OSTEOPOROSIS INT, 4(2), 117-119.
- BONE-MINERAL DENSITY AND VERTEBRAL COMPRESSION FRACTURE RATES IN ANKYLOSING-SPONDYLITIS. ANN RHEUM DIS, 53(2), 117-121.
- . Semin Arthritis Rheum, 23(4), 271.
- . Semin Arthritis Rheum, 23(4), 270.
- . Journal of Clinical Oncology, 12(1), 232-232.
- RENAL AND NONRENAL CLEARANCE OF CLODRONATE IN PATIENTS WITH MALIGNANCY AND RENAL IMPAIRMENT. DRUG INVEST, 7(1), 26-33.
- . Clin Oncol (R Coll Radiol), 6(3), 172-176.
- Double-blind trial of oral clodronate in breast cancer patients with bone metastases. Bulletin du cancer, 80(10 Suppl), 50-56.
- . Journal of Bone and Mineral Metabolism, 11(1), S17-S24.
- PREVALENCE OF VERTEBRAL FRACTURE IN WOMEN AND THE RELATIONSHIP WITH BONE-DENSITY AND SYMPTOMS - THE CHINGFORD STUDY. J BONE MINER RES, 8(7), 817-822.
- . Br J Urol, 72(1), 98-103.
- . Osteoporos Int, 3(3), 138-147.
- . Rheumatology, 32(suppl 1), 108-168.
- CLODRONATE IN HYPERCALCEMIA AND OSTEOLYTIC BONE-DISEASE DUE TO BREAST-CANCER. SAUDI MED J, 14(2), 93-97.
- . Br J Cancer, 67(3), 560-563.
- RISK OF VERTEBRAL FRACTURE IN WOMEN WITH RHEUMATOID-ARTHRITIS. BRIT MED J, 306(6877), 558-558.
- . Journal of Clinical Oncology, 11(1), 59-65.
- DOUBLE-BLIND CONTROLLED TRIAL OF ORAL CLODRONATE IN PATIENTS WITH BONE METASTASES FROM BREAST-CANCER. BULLETIN DU CANCER, 80(10), 50-65.
- . Osteoporos Int, 3 Suppl 2, S23-S28.
- . Eur J Haematol, 49(4), 192-198.
- HAJDU-CHENEY SYNDROME - A REPORT OF 2 CASES. J ORTHOP RHEUMATOL, 5(3), 163-169.
- . Bone and Mineral, 17, S29-S29.
- . Bone and Mineral, 17, S27-S27.
- . Bone and Mineral, 17, S28-S28.
- . Bone and Mineral, 17, S21-S21.
- . Bone and Mineral, 17, S25-S25.
- . Drug Safety, 7(2), 162-165.
- . Bone, 13 Suppl 2, S1-10.
- . Bone, 13(6), 431-433.
- . Clin Sci (Lond), 81(4), 543-549.
- . The Hastings Center Report, 21(5), S14-S14.
- Radiographic healing of osteolytic Paget's disease in the tibia with alendronate. Journal of Orthopaedic Rheumatology, 4(3), 153-157.
- The use of the Mennen clamp-on plate in the management of a pathological fracture. Journal of Orthopaedic Rheumatology, 4(3), 145-151.
- . Bone, 12(1), 17-20.
- . Bone, 12 Suppl 1, S13-S18.
- . J Bone Miner Res, 5(5), 483-491.
- . Clin Sci (Lond), 78(2), 221-225.
- . Clin Sci (Lond), 78(2), 215-219.
- . Clin Sci (Lond), 78(2), 227-233.
- USE OF DIPHOSPHONATES IN HYPERCALCEMIA DUE TO MALIGNANCY. LANCET, 335(8682), 170-171.
- . Bone, 11(5), 382-383.
- . Nephron, 56(1), 6-12.
- . BMJ, 299(6712), 1381-1382.
- . Bone, 10(6), 478-478.
- . Bone, 10(6), 476-477.
- Phosphate binding efficiency of a polyuronic acid in normal subjects.. Nephrol Dial Transplant, 4(9), 829-830.
- . Clin Sci (Lond), 74(6), 607-612.
- . Hematol Oncol, 6(2), 115-117.
- TRANSIENT TASTE-LOSS DURING TREATMENT WITH ETIDRONATE. LANCET, 2(8559), 637-637.
- . The Lancet, 330(8559), 637-637.
- TREATING PAGETS-DISEASE. BRIT MED J, 294(6587), 1612-1613.
- EFFECTS OF INTRAVENOUS ETIDRONATE DISODIUM ON SKELETAL AND CALCIUM-METABOLISM. AM J MED, 82(2A), 55-70.
- Transient taste-loss during treatment with etidronate. Acta Dermato-Venereologica, 67(4), 637.
- Clodronate in the medical management of hyperparathyroidism. Bone, 8(SUPPl. 1).
- Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.. Bone, 8 Suppl 1, S35-S41.
- Treatment of the hypercalcaemia of malignancy with intravenous clodronate.. Bone, 8 Suppl 1, S43-S51.
- DO ALL DIPHOSPHONATES HAVE HYPERPHOSPHATEMIC EFFECTS IN MAN. BONE, 7(4), 312-312.
- . JAMA Network Open, 7(12), e2448208-e2448208.
- . Clinical Chemistry and Laboratory Medicine (CCLM).
- . Osteoporosis International.
- . JAMA Oncology.
- . Calcified Tissue International.
- . Current Osteoporosis Reports.
- . Osteoporosis International.
- . Scandinavian Journal of Gastroenterology, 1-6.
- . Osteoporosis International.
- . Osteoporosis International.
- . Aging Clinical and Experimental Research, 36(1).
- . Current Opinion in Endocrinology, Diabetes & Obesity.
- . Nature Reviews Rheumatology.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International.
- . Journal of Bone and Mineral Research.
- . Journal of Bone and Mineral Research.
- . Journal of Cellular Signaling, 5(2), 57-64.
- . Rheumatology.
- . Journal of Endocrinological Investigation.
- . Journal of Bone and Mineral Research.
- . JAMA Network Open, 6(8), e2329253-e2329253.
- . Osteoporosis International.
- . The Journal of Clinical Endocrinology & Metabolism.
- . Osteoporosis International.
- . Osteoporosis International.
- . Osteoporosis International.
- . Archives of Osteoporosis, 18(1).
- . Osteoporosis International.
- . Quality of Life Research.
- . Osteoporosis International.
- . The Journal of Clinical Endocrinology & Metabolism.
- . Osteoporosis International.
- . The journal of nutrition, health & aging.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International.
- . Osteoporosis International.
- . Journal of Bone and Mineral Research.
- . Osteoporosis International.
- . JAMA Network Open, 5(6), e2215396-e2215396.
- . Aging Clinical and Experimental Research, 34(9), 2205-2215.
- . Osteoporosis International.
- . Osteoporosis International.
- . Journal of Bone and Mineral Research.
- . The American Journal of Clinical Nutrition.
- . The Journal of Frailty & Aging.
- . Climacteric, 1-7.
- . PAIN, JOINTS, SPINE, 11(2), 53-61.
- .
- . Osteoporosis International.
- . PAIN, JOINTS, SPINE, 9(4), 212-221.
- . Likarska sprava(5-6), 79-87.
- . ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS, 0(4), 68-74.
- . PAIN. JOINTS. SPINE, 0(3.23), 5-14.
- . TRAUMA, 17(5), 14-20.
- . Endocrine Abstracts.
- . Clinical Cases in Mineral and Bone Metabolism.
- . Osteoporosis and Bone Diseases, 17(3), 3-8.
- . Bone Abstracts.
- . Bone Abstracts.
- . Bone Abstracts.
- . PLoS Genetics, 8(7), e1002745-e1002745.
- . Journal of Bone and Mineral Research, 20(6), 913-920.
- . Journal of Bone and Mineral Research, 19(5), 728-736.
- . Journal of Bone and Mineral Research, 18(7), 1254-1260.
- . Journal of Bone and Mineral Research, 16(10), 1863-1870.
- . Osteoporosis International.
Chapters
- , Reference Module in Biomedical Sciences Elsevier
- , Senior Trauma Patients (pp. 89-99). Springer International Publishing
- , Pocket Reference to Osteoporosis (pp. 21-29). Springer International Publishing
- , Encyclopedia of Endocrine Diseases (pp. 288-295). Elsevier
- (pp. 331-339). Wiley
- , Osteoporosis: a lifecourse epidemiology approach to skeletal health (pp. 163-176). CRC Press
- , Osteoporosis: Fourth Edition (pp. 1611-1637).
- , Osteoporosis (pp. 1611-1637). Elsevier
- , Osteoporosis (pp. xix-xxiii). Elsevier
- , Osteoporosis in Men (pp. ix-xii). Elsevier
- , Osteoporosis in Men (pp. 605-611). Elsevier
- , Multiple Myeloma and Related Disorders (pp. 367-367). CRC Press
- , Paget鈥檚 Disease of Bone (pp. 112-134). Springer US
- , HRT and Osteoporosis (pp. 135-147). Springer London
- , Calcium Metabolism (pp. 89-136). S. Karger AG
Conference proceedings papers
- A SURROGATE FRAX MODEL FOR PERU. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S269-S269)
- Performance of FRAX in Men with Prostate Cancer: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 255-256)
- SHOULD THE PUNISHMENT FIT THE CRIME? OSTEOPOROSIS TREATMENT IN RELATION TO FRACTURE RISK. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S39-S39)
- FRAX Underestimates Major Osteoporotic Fracture Risk in Cancer Survivors: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 76-76)
- FRAXPLUS-POST HOC EXPLORATION OF IMPACT OF ADDITIONAL RISK FACTOR INFORMATION ON FRAX PROBABILITY CALCULATIONS. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S52-S52)
- EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S46-S46)
- COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN REAL WORLD USE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S581-S582)
- DIFFERENTIAL EFFECTS ON RISK OF FRACTURE AND DEATH BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S64-S65)
- EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S331-S331)
- OSTEOPOROSIS IN MEN: SCREENING, DIAGNOSIS AND IDENTIFICATION OF PATIENTS TO BE TREATED. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S76-S76)
- SARCOPENIA DEFINITIONS AND THEIR ASSOCIATION WITH FRACTURE RISK IN OLDER SWEDISH WOMEN. THE SAHLGRENSKA UNIVERSITY HOSPITAL PROSPECTIVE EVALUATION OF RISK OF BONE FRACTURES (SUPERB) STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S59-S59)
- Fracture Risk in Parkinson's Disease - the Role of Bone Density, Falls Risk and Muscle Strength. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 67-67)
- The Effect of Recent Fracture on 10-year Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 194-194)
- Discordance in Hip DXA Subregions Affects Incident Fracture Risk Independent of Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 27-27)
- CONCOMITANT PPI USE NEGATES ORAL BISPHOSPHONATE ANTI-FRACTURE EFFICACY: A POST HOC ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL OF CLODRONATE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S41-S41)
- Discordance in Hip DXA Subregions Affects Incident Fracture Risk Independent of Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 247-247)
- IMPROVED FRACTURE RISK PREDICTION BY ADDING VFA-IDENTIFIED VERTEBRAL FRACTURE DATA TO BMD BY DXA AND CLINICAL RISK FACTORS USED IN FRAX. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S42-S43)
- ADDED VALUE OF THE NEW VERSION OF THE FRAX (R) ALGORITHM. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S37-S38)
- FREM Affects Incident 10-year Fracture Risk Independent of FRAX (R) Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 305-306)
- UPDATE OF THE FRACTURE RISK PREDICTION TOOL FRAX: A SYSTEMATIC REVIEW OF POTENTIAL COHORTS AND ANALYSIS PLAN. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S256-S256)
- PRIMARY HYPERPARATHYROIDISM, BONE MINERAL DENSITY AND INCIDENT FRACTURE RISK: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S43-S43)
- Digital Health Interventions for Osteoporosis and Post-Fragility Fracture Care. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 184-184)
- EPIDEMIOLOGY OF HIP FRACTURE IN QATAR AND DEVELOPMENT OF A COUNTRY SPECIFIC FRAX MODEL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S235-S235)
- CHANGES IN HIP FRACTURE INCIDENCE IN ROMANIA AND IMPLICATIONS FOR FRAX. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S235-S236)
- FRAXPLUS. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S236-S237)
- MIGHT NSAID USE INTERACT WITH BISPHOSPHONATE EFFICACY? EXPLORATORY ANALYSIS FROM THE CLODRONATE HIP STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S56-S56)
- FRAX BASED OSTEOPOROSIS MANAGEMENT PATHWAY FOR UKRAINIAN MEN. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S278-S278)
- THE EFFECTIVENESS WORKING GROUP OF THE ROYAL OSTEOPOROSIS SOCIETY OSTEOPOROSIS AND BONE RESEARCH ACADEMY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S74-S75)
- RECENT SENTINEL FRACTURES AND SUBSEQUENT FRACTURE PROBABILITIES OVER TWO, FIVE AND 10-YEAR TIMEFRAMES. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S41-S41)
- TREATMENT GAP AMONG PATIENTS WITH PRIMARY OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S189-S190)
- IDENTIFICATION OF PATIENTS AT LOW, HIGH AND VERY HIGH RISK OF OSTEOPOROTIC FRACTURES IN THE UK USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S54-S55)
- SCREENING FOR HIGH FRAC TUR E RISK IN PRIMARY CARE. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S91-S92)
- PARATHYROIDECTOMY IS ASSOCIATED WITH REDUCED RISK OF FRACTURE AND CARDIOVASCULAR EVENTS IN PATIENTS DIAGNOSED WITH PRIMARY HYPERPARATHYROIDISM - A NATIONAL, RETROSPECTIVE COHORT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S47-S47)
- A SURROGATE FRAX MODEL FOR NEPAL. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S383-S383)
- A SURROGATE FRAX MODEL FOR ETHIOPIA. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S380-S380)
- FRACTURE RISK IN PARKINSON'S DISEASE: DRIVEN BY LOW BONE STRENGTH, MUSCLE WEAKNESS OR FALLS?. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S42-S43)
- EPIDEMIOLOGY OF HIP FRACTURES IN SAUDI ARABIA: DEVELOPMENT OF A COUNTRY SPECIFIC FRAX MODEL. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S383-S384)
- A SURROGATE FRAX MODEL IN ZIMBABWE. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S381-S382)
- FRAX BASED OSTEOPOROSIS MANAGEMENT PATHWAY FOR UKRAINIAN MEN. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S86-S86)
- Adjusting Fracture Probability for Prior Falls: A Registry-Based Cohort Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 316-316)
- Global impact of COVID-19 on osteoporosis management: A retrospective, longitudinal descriptive analysis of access to online MAX fracture risk assessments.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 212-212)
- General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: A Registry-Based Cohort Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 197-197)
- BUILDING A STRONGER FUTURE FOR POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S623-S623)
- Hormone therapy reduces the risk of fracture regardless of baseline FRAX probability or prior falls - results from the Women's Health Initiative hormone therapy trials. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 249-249)
- Adjusting Fracture Probability for the Effects of Recent Fracture: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 199-199)
- Crystal Bone: Personalized, Shot term Fracture Risk Prediction With Natural Language Processing, Methods. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 200-200)
- A CHRONIC DISEASE: GOING BEYOND TODAY WITH OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S625-S625)
- ALGORITHM FOR THE ASSESSMENT OF ANTI-OSTEOPOROSIS TREATMENTS BY BONE TURNOVER MARKERS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S66-S67)
- CLINICAL APPLICATION OF BONE TURNOVER MARKERS IN POST-MENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S65-S66)
- Comparison of Short:Term and 10-year Probabilities to Characterise Fracture Risk After a Recent Sentinel Fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 198-198)
- ESCEO-IOF ALGORITHM FOR THE MANAGEMENT OF PATIENTS AT LOW/HIGH/VERY HIGH RISK OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S33-S33)
- DIFFERENCES IN CLINICAL GUIDELINES. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S37-S37)
- DISABILITY-ADJUSTED LIFE YEARS RELATED TO FRAGILITY FRACTURES. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S320-S321)
- FRAX BASED INTERVENTION THRESHOLDS FOR UKRAINE. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S480-S480)
- pQCT Muscle Density Predicts Hip Fractures Independent of FRAX, Falls and BMD in the Osteoporotic Fractures in Men (MrOS) Study: a Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 159-159)
- External Validation of in 74,828 Patients from Manitoba, Canada: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 202-202)
- . Osteoporosis International, Vol. 31(1) (pp 67-75)
- . Osteoporosis International, Vol. 31(8) (pp 1499-1506)
- . Annals of Oncology, Vol. 30(Suppl 5) (pp v334-v335). Barcelona, Spain, 27 September 2019 - 1 October 2019.
- Genetic Risk Scores to Improve Osteoporosis Screening: Validation in External Cohorts. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 210-210)
- ADJUSTING FRAX FOR IMMINENT RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S166-S167)
- BURDEN OF FRAGILITY FRACTURES IN 6 EUROPEAN COUNTRIES. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S686-S686)
- APPENDICULAR LEAN MASS DOES NOT PREDICT INCIDENT FRACTURES INDEPENDENTLY OF BMD: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE (WHI) COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S356-S357)
- FRAX (R) TOOL WEBSITE USAGE IN THAILAND. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S374-S374)
- HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE HORMONE THERAPY TRIALS. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S163-S163)
- IMPROVING OSTEOPOROSIS CARE - GETTING CLOSER TO THE PATIENT. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S782-S782)
- EPIDEMIOLOGY OF OSTEOPOROTIC NONVERTEBRAL FRACTURES IN MOLDOVA. POPULATION-BASED LONGITUDINAL STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S450-S451)
- A POOLED ANALYSIS OF FALL INCIDENCE FROM PLACEBO-CONTROLLED TRIALS OF DENOSUMAB. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S179-S180)
- TEN-YEAR FRACTURE PROBABILITY IN SERBIA ACCORDING TO AGE AND OTHER FRAX MODELS IN THE REGION. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S489-S490)
- OSTEOPOROSIS (OP) DIAGNOSIS AND TREATMENT OF WOMEN AGED >= 70 YEARS IN PRIMARY CARE: RESULTS FROM A LARGE EUROPEAN CROSS-SECTIONAL STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S685-S686)
- TEN-YEAR FRACTURE PROBABILITY IN SYRIA USING A SURROGATE MODEL. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S489-S489)
- SECULAR CHANGES IN HIP FRACTURE INCIDENCE IN ECUADOR AND IMPLICATIONS FOR FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S490-S491)
- DO DEFINITIONS OF SARCOPENIA PREDICT FRACTURE RISK INDEPENDENT OF FRAX, FALLS AND BMD? A META-ANALYSIS OF THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S52-S52)
- FRAX is a good predictor of bone mineral density in people living with HIV of black ethnicity and/or low fracture risk. HIV MEDICINE, Vol. 20 (pp 39-40)
- Hormone therapy decreases the risk of fracture both in fallers and non-fallers - data from the combined Women's Health Initiative Hormone Therapy Trials. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 363-363)
- Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 102-102)
- Osteoporosis (OP) diagnosis and treatment of women aged >= 70 years in primary care: results from a large Europeal cross-sectional study. SWISS MEDICAL WEEKLY (pp 10S-10S)
- A POST HOC ANALYSIS OF ROMOSOZUMAB EFFICACY AND BASELINE FRACTURE RISK - GREATER REDUCTION IN FRACTURE OUTCOMES IN PATIENTS AT HIGHER RISK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 112-112)
- Subsequent Fracture Risk Following Traumatic versus Non-traumatic Fracture: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 53-53)
- Measured Height Loss Predicts Incident Clinical Fractures Independently from FRAX: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 100-100)
- Potential Impact of Recent Clinical Vertebral Fracture on FRAX 10year Probability. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 155-155)
- Loss in DXA-Estimated Total Body Lean Mass but not Fat Mass Predicts Incident Major Osteoporotic Fracture and Hip Fracture Independently from FRAX: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 21-21)
- EXPERIENCE AND PREFERENCE-BASED EQ-5D-3L VALUE SET DERIVED FROM LONGITUDINAL DATA: RESULTS FROM THE INTERNATIONAL COSTS AND UTILITIES OF OSTEOPOROTIC FRACTURES STUDY (ICUROS). VALUE IN HEALTH, Vol. 22 (pp S705-S706)
- OSTEOSARCOPENIC OBESITY: ENOUGH EVIDENCE FOR A DISTINCT ENTITY?. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S191-S192)
- WHEN AND WHY USE A BONE-FORMING AGENT?. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S157-S157)
- EPIDEMIOLOGY OF HIP FRACTURES IN UKRAINE: RESULTS OF STOP-STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S83-S83)
- DXA appendicular lean mass, FRAX, BMD and incident fractures: Findings from the Women's Health Initiative (WHI). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 155-155)
- Cost-effectiveness Evaluation of a Screening Programme for Fracture Risk in UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 398-399)
- Apparent Response Rate by PINP to Oral Bisphosphonates in Clinical Practice and Clinical Trial Settings. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 319-319)
- Genomic Prediction of Osteoporosis Using 426,000 Individuals from UK Biobank. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 39-39)
- PHYSICAL PERFORMANCE OR FUNCTION, BUT NOT APPENDICULAR LEAN MASS, PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX PROBABILITY AND BMD: RESULTS FROM THE OSTEOPOROTIC FRACTURES IN MEN (MROS) COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S69-S70)
- . Osteoarthritis and Cartilage, Vol. 26(Supplement 1) (pp S281-S281). Liverpool, United Kingdom, 26 April 2018 - 29 April 2018.
- AGN1 LOCAL OSTEO-ENHANCEMENT PROCEDURE (LOEP): AN EMERGING, MINIMALLY-INVASIVE SURGICAL TREATMENT TO ADDRESS OSTEOPOROSIS-RELATED BONE LOSS IN PROXIMAL FEMURS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S568-S569)
- (pp 720-728)
- Inappropriate Use of Cost-effectiveness Thresholds as Intervention Thresholds - Potential for Overtreatment of Low Risk Individuals. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 108-108)
- Definitions of sarcopenia as predictors of fracture risk independent of FRAX, falls and BMD: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 13-14)
- WOMEN IDENTIFIED AT HIGH RISK OF HIP FRACTURE BASED ON FRAX ARE RESPONSIVE TO APPROPRIATE OSTEOPOROSIS MANAGEMENT: ANALYSIS FROM THE SCOOP STUDY OF POPULATION SCREENING. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 613-614)
- DANGER OF OVERTREATMENT OF OSTEOPOROSIS WITH INAPPROPRIATE USE OF INTERVENTION THRESHOLDS DERIVED BY COST-EFFECTIVENESS ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S73-S73)
- Comparing Utility Loss Due to Fractures, in Cohorts With and Without a Previous Fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 392-393)
- Fracture Risk Assessment in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 47-48)
- Treatment gap following clinical vertebral fracture in the International Cost and Utility Related to Osteoporosis Fractures Study (ICUROS). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 115-115)
- INTERVENTION THRESHOLD BASED ON FRAX AND BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S504-S504)
- A MISSED OPPORTUNITY: WHAT PROPORTION OF FRACTURE PATIENTS HAVE HAD A PRIOR FRACTURE?. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S534-S534)
- AN UPDATE ON RISK ASSESSMENT AND FRACTURE PREVENTION IN EUROPEAN NATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S119-S120)
- UTILITY LOSS AFTER A SENTINEL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S72-S73)
- INFLAMMATION AND MUSCULOSKELETAL AGING. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S45-S45)
- IMPACT OF RECENT FRACTURE ON 10-YEAR PROBABILITY OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S478-S478)
- TREATMENT GAP FOLLOWING HIP FRACTURE IN THE INTERNATIONAL COST AND UTILITY RELATED TO OSTEOPOROSIS FRACTURES STUDY (ICUROS). OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S534-S534)
- SYSTEMATIC SCREENING USING FRAX LEADS TO INCREASED USE OF, AND ADHERENCE TO, ANTI-OSTEOPOROSIS MEDICATIONS: THE UK SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 613-613)
- EPIDEMIOLOGY OF FRACTURES IN ARMENIA: DEVELOPMENT OF A COUNTRY-SPECIFIC FRAX MODEL AND COMPARISON TO ITS SURROGATE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S423-S423)
- Offset of Effect of Oral Bisphosphonates on Tartrate-Resistant Acid Phosphatase in Postmenopausal Osteoporosis: the TRIO Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S379-S379)
- Effect of fracture risk assessment on anti-osteoporosis medication use and adherence: Findings from the SCOOP Trial.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S108-S108)
- MOBILITY RELATED RISK FACTORS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S61-S61)
- SKELETAL DETERMINANTS OF FRACTURE RISK - CAN WE DO BETTER?. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S118-S118)
- WHEN IS IT TIME TO STOP OSTEOPOROSIS TREATMENT?. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S46-S47)
- WOMEN IDENTIFIED AT HIGH RISK BASED ON FRAX HIP FRACTURE PROBABILITY ARE RESPONSIVE TO APPROPRIATE OSTEOPOROSIS MANAGEMENT: ANALYSIS FROM THE SCOOP STUDY OF POPULATION SCREENING. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S60-S60)
- THE EFFICACY OF ABALOPARATIDE-SC IS INDEPENDENT OF BASELINE BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S519-S519)
- Measures of physical performance or function, but not appendicular lean mass, predict new fractures independently of FRAX probability: Findings from MrOS.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S30-S30)
- Women Identified at High Risk of Hip Fracture based on FRAX are Responsive to Appropriate Osteoporosis Management: Results from the SCOOP Study of Population Screening.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S30-S30)
- PRIOR FALLS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S259-S259)
- FRAX for Fracture Prediction Shorter and Longer Than Ten Years: The Manitoba BMD Registry.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S29-S29)
- In Which Patient Populations Does Lumbar Spine Trabecular Bone Score (TBS) Have the Largest Effect on Fracture Prediction?.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S244-S244)
- Risk of Hip Fracture After Recent Fracture - Comparison of Sentinel Fracture Sites (Reykjavik Study).. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S251-S251)
- "Risk-Equivalent" T-score Adjustment Using Lumbar Spine Trabecular Bone Score (TBS): The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S93-S93)
- THE EFFECT OF ALENDRONATE ON VERTEBRAL FRACTURE RISK IS INDEPENDENT OF BASELINE FRAX FRACTURE PROBABILITY: A POST HOC ANALYSIS OF THE FIT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S619-S619)
- EPIDEMIOLOGY OF HIP FRACTURES IN UKRAINE: RESULTS OF STOP-STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S570-S570)
- TREATMENT BASED ON FRACTURE RISK - HEALTH ECONOMIC IMPLICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S101-S101)
- IMMINENT RISK OF HIP FRACTURE AFTER RECENT ( SENTINEL) FRACTURE - COMPARISON OF SENTINEL FRACTURE SITES (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S61-S62)
- ABALOPARATIDE-SC DECREASES VERTEBRAL, NONVERTEBRAL, MAJOR OSTEOPOROTIC, AND WRIST FRACTURES IN A SUBSET OF POSTMENO-PAUSAL WOMEN AT HIGH RISK OF FRACTURE BY FRAX SCORE. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S49-S50)
- Type 2 Diabetes Is Associated With Lower Prevalence Of Vertebral Fractures: A Meta-Analysis of Prospective Studies. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S95-S96)
- SCREENING BASED ON FRAX FRACTURE RISK ASSESSMENT REDUCES THE INCIDENCE OF HIP FRACTURES IN OLDER COMMUNITY-DWELLING WOMEN - RESULTS FROM THE SCOOP STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 624-624)
- IMPACT OF FALLS ON FRACTURES AND MORTALITY - AN OPPORTUNITY FOR INTERVENTION AND ENHANCEMENT OF FRACTURE PREDICTION?. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 617-617)
- WHAT IS THE PROFILE OF PATIENTS AT IMMINENT HIGH RISK OF FRACTURE?. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S692-S692)
- TREAT-TO-TARGET IN OSTEOPOROSIS AND OTHER CHRONIC DISORDERS: OPPORTUNITIES AND CHALLENGES. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S696-S696)
- TOWARDS AN OPERATIONAL DEFINITION OF SARCOPENIA. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S688-S689)
- Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials. JOURNAL OF RHEUMATOLOGY, Vol. 43(6) (pp 1208-1209)
- EFFECT OF INVESTIGATIONAL TREATMENT ABALOPARATIDE FOR PREVENTION OF MAJOR OSTEOPOROTIC FRACTURE OR ANY FRACTURE IS NOT ALTERED BY BASELINE FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S44-S45)
- A RANDOMIZED CONTROLLED TRIAL OF SCREENING IN THE COMMUNITY TO REDUCE FRACTURES IN OLDER WOMEN IN THE UK (THE SCOOP STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S42-S43)
- (pp 291-299)
- IMPACT OF FRACTURE RISK ASSESSMENT TOOLS ON PROPORTIONS OF WOMEN WITHOUT PRIOR FRACTURE IDENTIFIED AT RISK AND TREATED - LESSONS FROM THE SIGN GUIDANCE. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S382-S383)
- IMMINENT MAJOR OSTEOPOROTIC AND CLINICAL VERTEBRAL FRACTURE RISK AFTER FRACTURE (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S699-S700)
- FRAX IN THE WORLD TODAY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S563-S563)
- FRAX IN EUROPE - DEVELOPMENT AND THE NEXT STEPS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S564-S565)
- ONLINE USAGE OF FRAX FRACTURE RISK ASSESSMENT AND NATIONAL OSTEOPOROSIS GUIDELINE GROUP GUIDANCE BY UK CLINICAL PRACTITIONERS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S345-S345)
- QUALITY OF LIFE UP TO 18 MONTHS AFTER DISTAL FOREARM FRACTURE: RESULTS FROM THE ICUROS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S61-S62)
- FEMORAL NECK BMD IS STILL THE PREFERRED SITE IN THE ASSESSMENT OF HIP FRACTURE IN ELDERLY MEN (10-YEAR FOLLOW-UP OF MROS SWEDEN). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S58-S59)
- SWEDISH FARMERS HAVE LOWER RISK FOR HIP FRACTURE THAN EXPECTED FROM ECONOMIC STATUS, EDUCATION AND LOCATION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S56-S57)
- IMMINENT RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER FRACTURE (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S59-S59)
- OFFSET OF FRACTURE RISK AFTER TREATMENT CESSATION, A BASE FOR TRANSIENT TREATMENT INTERRUPTION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S33-S34)
- Can We Use Bone Turnover Markers As Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? an Analysis from Two Phase 3 Clinical Trials. ARTHRITIS & RHEUMATOLOGY, Vol. 67
- RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS TO TREAT SARCOPENIA. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S62-S62)
- EFFICACY OF TERIPARATIDE FOR PREVENTION OF VERTEBRAL AND NONVERTEBRAL FRACTURE IS NOT ALTERED BY BASELINE FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S203-S204)
- HIP AXIS LENGTH IS A FRAX AND BONE DENSITY INDEPENDENT RISK FACTOR FOR HIP FRACTURE IN MEN AND WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S50-S51)
- THE PREDICTIVE VALUE OF PAST FALLS FOR INCIDENT FALLS DECREASES, BUT THAT OF FRAX REMAINS STABLE, WITH INCREASING FOLLOW-UP TIME: FINDINGS FROM MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S143-S143)
- WORLDWIDE BURDEN OF HIGH FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S151-S152)
- FRAX PREDICTS INCIDENT FALLS IN ELDERLY WOMEN: FINDINGS FROM AUSTRALIA. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S152-S152)
- A META-ANALYSIS OF TRABECULAR BONE SCORE IN FRACTURE RISK PREDICTION AND ITS INTERACTION WITH FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S46-S46)
- WANING LONG-TERM PREDICTIVE VALUE OF FALLS HISTORY FOR INCIDENT FRACTURE: MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S42-S42)
- WANING LONG-TERM PREDICTIVE VALUE OF SERUM CTX FOR INCIDENT FRACTURE (OPRA COHORT). OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S364-S364)
- FRAX-BASED ASSESSMENT AND INTERVENTION THRESHOLDS: AN EXPLORATION OF THRESHOLDS IN WOMEN AGED 50 YEARS AND OLDER IN THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S54-S54)
- ASSESSMENT AND INTERVENTION THRESHOLDS IN THE UK - AN EXPLORATION OF ALTERNATIVE NOGG THRESHOLDS IN OLDER POSTMENOPAUSAL WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S673-S674)
- A META-ANALYSIS OF REFERENCE MARKERS OF BONE TURNOVER FOR PREDICTION OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S314-S315)
- DERIVATION OF A LUMBAR SPINE TRABECULAR BONE SCORE (TBS) ADJUSTMENT RATIO FOR FRAX: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S408-S409)
- A META-ANALYSIS OF THE EFFECT OF STRONTIUM RANELATE ON THE RISK OF VERTEBRAL AND NON-VERTEBRAL FRACTURE IN POSTMENOPAUSAL OSTEOPOROSIS: THE IMPACT OF SEVERE OSTEOPOROSIS AND CONTRAINDICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S120-S121)
- EFFICACY OF TERIPARATIDE ON THE RISK OF VERTEBRAL FRACTURE AND THE INTERACTION WITH FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S324-S324)
- DECLINING HIP FRACTURE RISK IN SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S318-S319)
- HOSPITALIZED AND NONHOSPUIALIZED VERTEBRAL FRACTURES: COMPARISON OF PATIENT DEMOGRAPHICS AND HEALTH RELATED QUALITY OF LIFE IMPLICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S109-S110)
- WHICH FRAX MODEL IS APPROPRIATE FOR SWEDISH IMMIGRANTS?. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S122-S122)
- WAYS TO REDUCE OSTEOPOROSIS TREATMENT GAP IN ROMANIA. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S229-S230)
- QUANTITATIVE ULTRASOUND (QUS) IS ASSOCIATED WITH FRACTURE RISK: A META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S108-S108)
- THE INCIDENCE OF A FIRST MAJOR OSTEOPOROTIC FRACTURE IN ICELAND AND IMPLICATIONS FOR FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S316-S316)
- FRAX BASED GUIDELINES: IS A UNIVERSAL MODEL APPROPRIATE?. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S121-S122)
- GOAL ORIENTED TREATMENT IN OSTEOPOROSIS: LESSONS FROM OTHER DISEASES AREAS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S144-S144)
- PREVENTION OF BONE METASTASES. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S152-S152)
- Performance Characteristics of Heel Quantitative Ultrasound (QUS) for the Assessment of Fracture Risk; an Individual-level Meta-analysis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S177-S177)
- FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S321-S321)
- Is the Swedish FRAX Model Appropriate for Immigrants to Sweden?.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S305-S305)
- Assessment and Intervention Thresholds for FRAX probabilities in the UK - An Evaluation of adjusting Thresholds in Older Postmenopausal Women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S46-S46)
- COUNTRY, CULTURE & RISK IN ASIA-PACIFIC. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S515-S515)
- COST-EFFECTIVE FRAX PROBABILITY THRESHOLDS FOR ALENDRONIC ACID USE IN TAIWAN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S587-S588)
- DERIVATION OFA LUMBAR SPINE TRABECULAR BONE SCORE (TBS) ADJUSTMENT RATIO FOR FRAX: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S624-S625)
- LUMBAR SPINE TEXTURE FROM TBS ENHANCES FRACTURE RISK ASSESSMENT IN CLINICAL PRACTICE: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S555-S556)
- Development of the FRAX model for Ireland. IRISH JOURNAL OF MEDICAL SCIENCE, Vol. 182 (pp S103-S103)
- Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- The Performance of FRAX (R) According to Different Levels of Socioeconomic Status. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- LUMBAR SPINE TRABECULAR BONE SCORE (TBS) IS A FRAX INDEPENDENT RISK FACTOR FOR FRACTURE: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S308-S308)
- MILD MORPHOMETRIC VERTEBRAL FRACTURES PREDICT VERTEBRAL FRACTURES BUT NOT NONVERTEBRAL FRACTURES. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S310-S311)
- THE WORLDWIDE BURDEN OF HIP FRACTURES AND THE IMPACT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S270-S270)
- BONE AREA OF THE RADIUS CONTRIBUTES TO HIP FRACTURE RISK INDEPENDENTLY OF BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S268-S269)
- THE EFFECT OF LATITUDE AND SEASONAL VARIATION ON THE RISK OF HIP FRACTURE IN SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S46-S47)
- ASSESSMENT OF OSTEOPOROSIS: EUROPEAN GUIDANCE FOR THE DIAGNOSIS, ASSESSMENT AND TREATMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S80-S81)
- ADIPONECTIN AND 10-YEAR PROBABILITY OF FRACTURE IN ELDERLY MEN: MR OS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S47-S47)
- SECONDARY PREVENTION: A CALL TO ACTION. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S28-S29)
- The Quality Of Life and Resource Use Related To Hip Fractures Based On Data From The International Costs and Utilities Related To Osteoporotic Fractures Study.. ARTHRITIS AND RHEUMATISM, Vol. 65 (pp S520-S520)
- Successful Sage-grouse Show Greater Laterality in Social Behaviors. INTEGRATIVE AND COMPARATIVE BIOLOGY, Vol. 53 (pp E313-E313)
- FRAX (R) Predicts Future Falls in Elderly Men. MrOs Sweden. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- Lumbar Spine Trabecular Bone Score (TBS) combined with FRAX improves fracture prediction: The Manitoba BMD Cohort. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- Can Changes in FRAX Probability Be Used to "Treat-to-Target"? A Clinical Feasibility Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- Could Fracture Risk Assessment in Elderly Men Be Improved by Adiponectin? Mr Os Sweden. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- Markers of Bone Turnover for Prediction of Fracture: a Meta-analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- Total Body Lean Mass and Fat Mass Differentially Affect Hip BMD and Strength Index in Women and Men But Are Not FRAX Independent Risk Factors for Fracture: A Large Clinical Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- STRUCTURE ANALYSIS OF THE HIP QCT SCANS AND HIP FRACTURE RISK IN OLDER WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S579-S579)
- . Bone, Vol. 50 (pp S52-S53)
- . Bone, Vol. 50 (pp S33-S34)
- FRAX: WHERE ARE WE NOW?. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S54-S54)
- CURRENT CONTROVERSIES IN PRIMARY AND SECONDARY FRACTURE PREVENTION. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S53-S53)
- A META-ANALYSIS OF THE ASSOCIATION BETWEEN FALLS AND HIP FRACTURE RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S80-S81)
- HIGH BODY MASS INDEX, ADJUSTED FOR BMD, IS A RISK FACTOR FOR FRACTURE IN WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S311-S312)
- IMPACT OF LUMBAR SPINE BMD ON FRAX IN WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S65-S66)
- WNT16 IS ASSOCIATED WITH BONE MINERAL DENSITY, OSTEOPOROTIC FRACTURE AND BONE STRENGTH: A LARGE-SCALE META-ANALYSIS OF GENOMEWIDE ASSOCIATION STUDIES. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S402-S403)
- IS ANXIETY ASSOCIATED WITH FRACTURE RISK AND ADHERENCE TO TREATMENT? FINDINGS FROM THE MRC SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S200-S200)
- THE ECONOMIC BURDEN OF FRACTURES IN THE EUROPEAN UNION IN 2010. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S57-S57)
- ANXIETY, FRACTURE RISK AND ADHERENCE TO TREATMENT: THE MRC SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S531-S531)
- PITFALLS IN THE VALIDATION OF FRACTURE RISK ASSESSMENT TOOLS. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S302-S303)
- FRAX (R) WITHOUT BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S305-S305)
- EVIDENCE BASED EVALUATION OF CLINICAL RISK FACTORS USED IN THE ASSESSMENT OF FRACTURE RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S309-S310)
- HIGH SERUM ADIPONECTIN PREDICTS INCIDENT FRACTURES IN ELDERLY MEN: MR OS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S306-S307)
- LIMITATIONS OF AREA UNDER THE ROC CURVE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S196-S196)
- COMPARING OUTPUTS OF THE FRAX AND GARVAN FRACTURE RISK ASSESSMENT TOOLS. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S306-S306)
- FINAL RESULTS OF A 3 YEARS PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S73-S73)
- A SYSTEMATIC REVIEW OF HIP FRACTURE INCIDENCE AND PROBABILITY OF FRACTURE WORLDWIDE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S308-S308)
- . Osteoarthritis and Cartilage, Vol. 19 (pp S179-S179)
- . Bone, Vol. 48 (pp S71-S72)
- NEW INTERIM ANALYSIS OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS (N=13,069) TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 269-270)
- FRAX (R) 2 YEARS AFTER ITS LAUNCH. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 94-94)
- DENOSUMAB REDUCES THE RISK OF CLINICAL OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN, PARTICULARLY IN THOSE WITH MODERATE TO HIGH FRACTURE RISK AS ASSESSED WITH FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 103-103)
- Care of the elderly: Preventing osteoporotic fractures in older people. Practitioner, Vol. 255(1736) (pp 19-22)
- THE BURDEN OF FRACTURES IN FRANCE, GERMANY, ITALY, SPAIN, SWEDEN, AND THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 97-97)
- Increasing Age and Sex Specific Rates of Hip Fracture in Mexico. Projections for 2050. JOURNAL OF RHEUMATOLOGY, Vol. 38(6) (pp 1197-1197)
- KEEPING UP TO DATE: CLINICAL DECISION MAKING - WHAT IS THE EVIDENCE? OSTEOPOROSIS. RHEUMATOLOGY, Vol. 50 (pp 3-3)
- A COMPARISON OF CASE-FINDING STRATEGIES FOR THE MANAGEMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 270-270)
- GUIDANCE FOR THE ADJUSTMENT OF FRAX (R) ACCORDING TO THE DOSE OF GLUCOCORTICOIDS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp S771-S772)
- LOW VITAMIN D IS RELATED TO INCREASED RISK OF DEATH IN ELDERLY MEN: MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp S772-S772)
- DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 20-20)
- THE PATTERN OF MORTALITY ASSOCIATED WITH BONE MINERAL DENSITY IN ELDERLY MEN - MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 101-102)
- FRAX (R) AND THE EFFECT OF RALOXIFENE ON VERTEBRAL AND NON-VERTEBRAL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 22-22)
- A TRANSLATIONAL APPROACH TO CLINICAL GUIDELINE DEVELOPMENT WITH FRAX (R) BASED ON THE GUIDELINES FOR SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 331-331)
- BAZEDOXIFENE REDUCES NON-VERTEBRAL FRACTURES IN PATIENTS AT HIGH PROBABILITY OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 205-206)
- A COMPARISON OF CASE-FINDING STRATEGIES FOR THE MANAGEMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 330-330)
- . Bone, Vol. 46 (pp S26-S26)
- NEW INTERIM ANALYSIS OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 166-166)
- . Bone, Vol. 44 (pp S375-S376)
- . BONE, Vol. 44(2) (pp S382-S383)
- . BONE, Vol. 44(2) (pp S205-S205)
- NOVEL ANALYSIS OF MARGOLIS DIAGRAM ALLOWS IDENTIFICATION OF UNDERLYING VERTEBRAL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S269-S269)
- NOVEL ANALYSIS OF MARGOLIS PAIN DIAGRAM ALLOWS IDENTIFICATION OF UNDERLYING VERTEBRAL FRACTURE. RHEUMATOLOGY, Vol. 48 (pp I12-I12)
- The effect of a history of thyroid disease in skeletal and muscle health and the risk of fractures in elderly women. EUR J CLIN INVEST, Vol. 39 (pp 3-3)
- ASSESSMENT AND INTERVENTION THRESHOLDS FOR THE UK USING FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S281-S281)
- IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S266-S266)
- IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S200-S200)
- BAZEDOXIFENE REDUCES ALL CLINICAL FRACTURES AND MORPHOMETRIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN AT INCREASED FRACTURE RISK ASSESSED BY FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S199-S200)
- EFFICACY OF ONCE-MONTHLY ORAL BISPHOSPHONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 146-146)
- GOOD SAFETY AND PERSISTENCE OF STRONTIUM RANELATE IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 94-94)
- FRAX (R): WHAT IT IS AND WHAT IT ISN'T. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 183-183)
- IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 32-32)
- BAZEDOXIFENE REDUCES ALL CLINICAL FRACTURES AND MORPHOMETRIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN AT INCREASED FRACTURE RISK ASSESSED WITH FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 16-17)
- COST-EFFECTIVENESS OF BAZEDOXIFENE IN THE UK AND SWEDEN INCORPORATING THE FRAX (R)-ALGORITHM. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 13-13)
- CASE FINDING FOR THE MANAGEMENT OF OSTEOPOROSIS WITH FRAX庐 - ASSESSMENT AND INTERVENTION THRESHOLDS FOR THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 19-19)
- Use of DXA-based structural engineering models of the proximal femur to predict hip fracture. CALCIFIED TISSUE INT, Vol. 83(1) (pp 5-6)
- . JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol. 93(3) (pp 852-860)
- Impact of Varying BMD Resources on Prediction of Hip Fracture using FRAX (TM). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S305-S305)
- Case Finding for the Management of Osteoporosis with FRAX - Assessment and Intervention Thresholds for the UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S82-S82)
- Incorporating FRAX (TM) Algorithms in Models of Cost-effectiveness. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S8-S8)
- Can fall risk be incorporated into fracture risk assessment algorithms?: A pilot study of responsiveness to bisphosphonates. CALCIFIED TISSUE INTERNATIONAL, Vol. 83(1) (pp 18-18)
- Can fall risk be incorporated into fracture risk assessment algorithms: A pilot study of responsiveness to bisphosphonates. CALCIFIED TISSUE INTERNATIONAL, Vol. 82 (pp S54-S54)
- Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. OSTEOPOROSIS INTERNATIONAL, Vol. 19(11) (pp 1675-1675)
- Vertebral deformities in men: How many are osteoporotic?. OSTEOPOROSIS INTERNATIONAL, Vol. 19(11) (pp 1664-1664)
- Use of DXA-Based structural engineering models of the proximal femur to predict hip fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S116-S116)
- Abdominal Aortic Calcification (AAC) on Vertebral Fracture Assessment (VFA) images predicts incident myocardial infarction and stroke independent of clinical cardiovascular disease risk factors. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S22-S22)
- Interaction between body mass index and bone turnover during aromatase inhibition: Evidence from the Letrozole (L), Exemestane (E), and Anastrozole (A) Pharmacodynamics (LEAP) trial. BONE, Vol. 40(6) (pp S161-S162)
- Bone mineral density response to 2 years of continuous treatment with teriparatide: Final results from the EUROFORS study. OSTEOPOROSIS INTERNATIONAL, Vol. 18 (pp S7-S7)
- Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S17-S17)
- Assessment of absolute fracture risk. ANNALS OF THE RHEUMATIC DISEASES, Vol. 66 (pp 29-29)
- Comparison of European and WHO strategies for the identification of women at risk of hip fracture. OSTEOPOROSIS INTERNATIONAL, Vol. 18 (pp S23-S23)
- Interaction between body mass index and bone turnover during aromatase inhibition: Evidence from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial. JOURNAL OF CLINICAL ONCOLOGY, Vol. 25(18)
- Bone thinning: Prevalent in COPD but early detection allows treatment opportunity before vertebral fracture occurs. THORAX, Vol. 61 (pp II83-II83)
- Use of clinical risk factors to identify postmenopausal women with vertebral fractures.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S275-S275)
- Offset of effect of bisphosphonates on fracture incidence - Evidence from a prospective controlled trial of clodronate.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S71-S71)
- The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S71-S71)
- A DXA-based composite beam model of the proximal femur for stress estimation. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1161-1161)
- The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIS) in healthy postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1160-1160)
- The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 24(18) (pp 16S-16S)
- A comparison of bone mineral measurements for fracture prediction: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S162-S162)
- Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S131-S131)
- (Poster prize nominee - highly commended) - Use of clinical risk factors to identify postmenopausal women with vertebral fractures. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp 408-409)
- A comparison of bone mineral measurements for fracture prediction: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S9-S9)
- Complete data from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamic (PD) 'LEAP' trial: direct comparison of safety parameters between aromatase inhibitors (Als) in healthy postmenopausal women.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 100 (pp S111-S111)
- Response of BMD to 24 months of teriparatide (rhPTH 1-34) in patients with and without prior antiresorptive treatment: Final results from the EUROFORS study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S43-S43)
- Mild primary hyperparathyroidism is associated with low BMD, but not fracture risk, quality of life or mortality in community dwelling elderly women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1149-1149)
- Using risk factors for the diagnosis and treatment of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S113-S114)
- A DXA-based composite beam model of the proximal femur for stress estimation. CALCIFIED TISSUE INTERNATIONAL, Vol. 78 (pp S165-S165)
- The cross section geometry of the femoral neck.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S65-S65)
- A comparison of total hip BMD as a predictor of fracture risk: A meta-analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S4-S4)
- Effects of oral clodronate (BONEFOS (R)) therapy on bone turnover and skeletal metastases in women with primary breast cancer.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 94 (pp S21-S21)
- Initial results from the LEAP Study: the first direct comparison of safety parameters between aromatase inhibitors (AIs) in healthy postmenopausal women. BREAST CANCER RESEARCH AND TREATMENT, Vol. 94 (pp S101-S102)
- Skeletal protective effect of clodronate in primary breast cancer-bone mass, bone turnover, and skeletal-related events (SRE's). EJC SUPPLEMENTS, Vol. 3(2) (pp 97-97)
- Characteristics associated with non-persistence during daily therapy - Experience from the placebo wing of a community-based clinical trial.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S282-S282)
- Utility of MXA for detecting prevalent fractures - Experience from a large epidemiological study. BONE, Vol. 36 (pp S116-S116)
- Oral clodronate maintains bone mass in women with primary breast cancer.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 23(16) (pp 12S-12S)
- Vertebral deformities in men: How many are osteoporotic?. OSTEOPOROSIS INTERNATIONAL, Vol. 16(5) (pp S6-S7)
- Early offset of the action of clodronate after 3 years of treatment in osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S55-S56)
- A meta-analysis of milk intake and fracture risk. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S429-S429)
- A family history of fracture and fracture risk: A meta-analysis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S91-S91)
- Plasma retinol and retinyl esters as predictors of incident osteoporotic fracture in elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S6-S6)
- A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 22(14) (pp 743S-743S)
- Fractures and all-cause mortality in a population sample of elderly women; Observations from the MRC HIP study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19(6) (pp 1032-1032)
- Smoking and fracture risk: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S10-S10)
- Fractures and all-cause mortality in a population sample of elderly women: Observations from the MRC HIP study. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S9-S9)
- A meta-analysis of BMD as a predictor of fracture risk. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S5-S5)
- Mild primary hyperparathyroidism is associated with low BMD but not fracture risk, quality of life or mortality in community dwelling elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S102-S102)
- Oral clodronate for adjuvant treatment of operable breast cancer: Results of a randomized, double-blind, placebo-controlled multicenter trial. JOURNAL OF CLINICAL ONCOLOGY, Vol. 22(14) (pp 9S-9S)
- EFFECT OF MEDICAL RISK FACTORS, MUSCLE STRENGTH AND FALLS HISTORY ON FRACTURE INCIDENCE. RHEUMATOLOGY, Vol. 43 (pp 56-56)
- Oral clodronate (BONEFOS (R)) reduces skeletal complications and mortality in breast cancer patients with bone metastases: retrospective analysis of patients from a randomized, placebo-controlled trial. BREAST CANCER RESEARCH AND TREATMENT, Vol. 88 (pp S131-S131)
- Offset of the action of Clodronate (Bonefos (R)) after 3 years of treatment in women with osteoporosis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S159-S159)
- Does the location of the parathyroid adenoma influence kidney stone formation in primary hyperparathyroidism?. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S391-S391)
- The use of BMD for therapeutic decision making.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S57-S57)
- The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S92-S92)
- Semi-automated metacarpal morphometry (metacarpal cortical index) predicts fracture risk in elderly women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18(7) (pp 1374-1374)
- The use of plain radiograph of the calcaneum for evaluation of osteoporosis?. BONE, Vol. 32(5) (pp S179-S179)
- Optimisation of case finding with bone mineral density. BONE, Vol. 32(5) (pp S142-S142)
- A meta-analysis of previous fracture and fracture risk. BONE, Vol. 32(5) (pp S84-S84)
- Adjuvant clodronate therapy in primary operable breast cancer - Duration and offset of effects on bone mineral density. OSTEOPOROSIS INTERNATIONAL, Vol. 14 (pp S10-S10)
- The prevalence of unrecognised adult coeliac disease in patients with reduced bone mineral density: A case finding approach. GUT, Vol. 52 (pp A38-A38)
- Digital X-ray radiogrammetry (DXR) of the metacarpals in the prediction of vertebral fracture and monitoring bone density in a study of Clodronate therapy. OSTEOPOROSIS INTERNATIONAL, Vol. 14 (pp S6-S6)
- Relative importance of BMD, markers of bone turnover, height and body weight as predictors of hip fracture - A prospective case-control study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S84-S84)
- Metacarpal BMD and cortical index are significant predictors of hip fracture.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S65-S65)
- A meta-analysis of body mass index (BMI) as a predictor of fracture risk. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S21-S21)
- Biochemical markers of bone turnover are associated with risk of bone metastases in women with primary operable breast cancer. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18(7) (pp 1362-1362)
- Maternal hip fracture and current smoking are not associated with hip fracture risk in elderly women in the UK.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S462-S462)
- Nasal calcitonin increases spinal bone density in male osteoporosis without vertebral deformity.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S275-S275)
- Senile defect in the renal activation of vitamin D.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S277-S277)
- Digital X-ray radiogrammetry indices,particularly MCI, can predict vertebral fracture risk in osteoporotic women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S186-S186)
- Digital X-ray radiogrammetry indices are sensitive to clodronate treatment in women with osteoporosis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S231-S231)
- Serum PINP, an index of bone turnover, but not bone mineral density, may be predictive of bone metastases in women with primary operable breast cancer.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 76 (pp S142-S142)
- Changes can be monitored by digital X-ray radiogrammetry (DXR) in women on clodronate treatment for osteoporosis. RADIOLOGY, Vol. 225 (pp 419-419)
- Clodronate decreases the incidence of skeletal metastases in primary breast cancer - A randomised, placebo-controlled study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S185-S185)
- Safety profile of oral clodronate during long-term use in breast cancer patients. BONE, Vol. 30(3) (pp 46S-46S)
- Digital X-ray Radiogrammetry predicts hip fracture in elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16 (pp S194-S194)
- BMD at diagnosis of primary operable breast doesn't influence the incidence of skeletal metastases.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16 (pp S455-S455)
- HIP axis length a predictor of HIP fracture in elderly women in England. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16(6) (pp 1182-1182)
- Prevalence and causes of low bone density and fractures in kidney transplant patients.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 15 (pp S571-S571)
- Health and vitamin D status in osteoporotic patients with and without vertebral fracture. OSTEOPOROSIS INTERNATIONAL, Vol. 11 (pp S97-S97)
- Clinical assessment of bone mass, quality and architecture. OSTEOPOROSIS INTERNATIONAL, Vol. 9 (pp 24-28)
- Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 12 (pp S490-S490)
- COLIA1 Sp1 polymorphism and bone mass in elderly women. J BONE MINER RES, Vol. 12 (pp S547-S547)
- The effect of oral clodronate on bone mineral density in women with primary breast cancer. EUROPEAN JOURNAL OF CANCER, Vol. 33 (pp 344-344)
- Clodronate as an adjuvant to hormone and chemotherapy in patients with breast cancer. ADJUVANT THERAPY OF CANCER VIII, Vol. 8 (pp 153-162)
- Vertebral fracture, loss of height and treatment with clodronate in myeloma.. J BONE MINER RES, Vol. 11 (pp T732-T732)
- Image-based ultrasound attenuation assessment of the heel.. J BONE MINER RES, Vol. 11 (pp S611-S611)
- Effect of clodronate on the natural history of myelomatosis. BRIT J HAEMATOL, Vol. 93 (pp 1136-1136)
- Bone measurements with DXA and ultrasound: Diagnostic and prognostic use. OSTEOPOROSIS 1996, Vol. 1118 (pp 181-190)
- Tibial ultrasound velocity and skeletal status in the normal population.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 11 (pp S632-S632)
- Comparison of normative data for skeletal assessment at the spine, hip and forearm.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 11 (pp S588-S588)
- Effect of clodronate on progression of skeletal disease in multiple myelomatosis. EUR J CANCER, Vol. 31A (pp 775-775)
- Effect of oral clodronate in women with recurrent breast cancer in the absence of skeletal metastases. EUR J CANCER, Vol. 31A (pp 368-368)
- CLODRONATE DECREASES THE FREQUENCY OF SKELETAL METASTASES IN WOMEN WITH BREAST-CANCER. J BONE MINER RES, Vol. 10 (pp S194-S194)
- PHYSICAL RISK-FACTORS FOR HIP FRACTURE IN ELDERLY WOMEN IN THE COMMUNITY AND NURSING-HOMES. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S362-S362)
- A COMPARISON OF RADIOGRAPHIC VERTEBRAL MORPHOMETRY AND MXA IN ESTABLISHED VERTEBRAL OSTEOPOROSIS. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S473-S473)
- ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S356-S356)
- SKELETAL STATUS OF ELDERLY WOMEN WITH AND WITHOUT VERTEBRAL DEFORMITY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S473-S473)
- PAGETS-DISEASE OF BONE AND UNVACCINATED DOGS. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S404-S404)
- INCIDENCE OF VERTEBRAL DEFORMITY IN POSTMENOPAUSAL WOMEN - THE CHINGFORD-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S260-S260)
- VARIATIONS IN VERTEBRAL DEFORMITY PREVALENCE IN EUROPE ARE STATISTICALLY DEPENDENT ON POPULATION DIFFERENCES IN BONE-DENSITY - THE EVOS-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S260-S260)
- THE EFFECT OF ORAL ALENDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF THE BONE. J BONE MINER RES, Vol. 8 (pp S286-S286)
- COMPLIANCE AND EFFICACY OF CLODRONATE IN METASTATIC SKELETAL DISEASE IN BREAST-CANCER. J BONE MINER RES, Vol. 8 (pp S286-S286)
- RISK-FACTORS IN SENILE OSTEOPOROSIS. RECENT ADVANCES IN AGING SCIENCE, VOLS I AND II (pp 1145-1150)
- Treatment of established osteoporosis. European Journal of Internal Medicine, Supplement, Vol. 3(1) (pp 125-133)
- THE PREVALENCE OF VERTEBRAL FRACTURES IN FEMALES WITH RHEUMATOID-ARTHRITIS. ARTHRITIS RHEUM, Vol. 35(9) (pp S130-S130)
- ORAL CLODRONATE REDUCES SKELETAL MORBIDITY IN METASTATIC BREAST-CANCER. J BONE MINER RES, Vol. 7 (pp S152-S152)
- RELATIONSHIP BETWEEN CRITERIA FOR VERTEBRAL DEFORMITY AND BONE MASS IN A POPULATION STUDY. J BONE MINER RES, Vol. 7 (pp S137-S137)
- EFFECTS OF ORAL DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) IN THE TREATMENT OF PAGETS-DISEASE OF BONE. J BONE MINER RES, Vol. 7 (pp S293-S293)
- EFFECTS OF INTRAVENOUS DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) IN THE TREATMENT OF PAGETS-DISEASE OF BONE. J BONE MINER RES, Vol. 7 (pp S292-S292)
- ASSESSMENT OF VERTEBRAL DEFORMITY - VALIDATION OF A NEW METHOD WITH HIGH SPECIFICITY. J BONE MINER RES, Vol. 7 (pp S185-S185)
- THE PREVALENCE OF VERTEBRAL FRACTURES IN FEMALES WITH RHEUMATOID-ARTHRITIS. BRIT J RHEUMATOL, Vol. 31 (pp 94-94)
- TREATMENT OF SKELETAL DISEASE IN BREAST-CANCER WITH CLODRONATE. BONE, Vol. 12 (pp S25-S30)
- BISPHOSPHONATES IN THE MANAGEMENT OF HYPERCALCEMIA OF MALIGNANCY. TUMOUR INDUCED HYPERCALCAEMIA AND ITS MANAGEMENT, Vol. 176 (pp 59-70)
- DIAGNOSTIC METHODOLOGY IN THE EVALUATION OF OSTEOPOROSIS. REHABILITATION MEDICINE /, Vol. 928 (pp 79-94)
- OPTIMIZING TREATMENT OF PAGETS-DISEASE OF BONE. CALCIFIED TISSUE INTERNATIONAL, Vol. 39 (pp A75-A75)
- CALCIUM AND PHOSPHATE HOMEOSTASIS IN DISSEMINATED PROSTATIC-CANCER - EVIDENCE FOR SECONDARY HYPERPARATHYROIDISM. CALCIFIED TISSUE INT, Vol. 39 (pp A107-A107)
- . Bone Abstracts
Datasets
Preprints
- Research group
-
Current Collaborators
- Prof T Skerry
- Prof M Brown
Postgraduate Students
- Lucy Harris
- Teaching activities
-
I am the educational lead and teaching coordinator for Musculoskeletal Medicine across the various phases of the undergraduate curriculum at the University of 91直播, as well as teaching on postgraduate courses (e.g. MSc in Molecular Medicine, Molecular and Cellular Basis of Disease module).
- Professional activities and memberships
-
I am currently secretary of the Bone Research Society, chair of the American Society for Bone and Mineral Research Ancillary Program Committee and a member of the National Specialty Group for Musculoskeletal Diseases.
I also chair the Implementation Committee of the National Osteoporosis Guidance Group.